Indianara de Vargas

Indianara de Vargas

Auto-generated profile, based on publicly available information

Indianara de Vargas

Programa de Pós-Graduação em Medicina Veterinária, Universidade Federal de Santa Maria, Santa Maria, Brasil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2023 in Veterinary and Comparative Oncology
Verified
Journal Article
Closed access
ASAlex dos Santos
Alex dos Santos
ELEryca Ceolin Lamego
Eryca Ceolin Lamego
LELuíza Müller Eisenhardt
Luíza Müller Eisenhardt
IVIndianara de Vargas
Indianara de Vargas
MFMariana Martins Flores
Mariana Martins Flores
GKGlaucia D. Kommers
Glaucia D. Kommers

22 April 2026 in Brazilian Journal of Microbiology
Verified
Journal Article
Open access
PDF file
ESEduarda Maria Trentin Santi
Eduarda Maria Trentin Santi
JPJoana Braga Pecego
Joana Braga Pecego
MSMaria Fernanda Abel Schirmer
Maria Fernanda Abel Schirmer
TVThainã Piccolo Vargas
Thainã Piccolo Vargas
VMValentina Berté Marcus
Valentina Berté Marcus
MFMariana Martins Flores
Mariana Martins Flores
Equus caballus papillomavirus type 2 (EcPV-2) has been recently associated with the development of genital squamous cell carcinomas in horses. Nevertheless, its circulation among healthy, asymptomatic horses remains poorly understood. This study aimed to investigate the presence of EcPV-2 DNA in asymptomatic horses submitted to necropsy in southern Brazil. A total of 54 horses without clinical or histological evidence of genital lesions were investigated: 40 necropsied animals and penile mucosa specimens collected from 14 horses at a local abattoir. Tissue samples were subjected to histological analysis and polymerase chain reaction targeting a 306 bp fragment of the EcPV-2 L1 gene. EcPV-2 DNA was detected in one animal (1.85%). The sample was obtained from a necropsied male horse that died due to acute intestinal disease. Sequencing of the amplicon obtained in the PCR confirmed the identity of the viral fragment, and phylogenetic analysis clustered the sequence with known EcPV-2 isolates. No histological lesions were observed in any of the tissues examined from the animal containing amplifiable EcPV-2 DNA. This is the first report of EcPV-2 DNA detection in the genital mucosa of an asymptomatic horse in Brazil, supporting the possibility of subclinical infection. These findings provide initial evidence that EcPV-2 may occur in clinically normal horses in Brazil and highlight the need for further studies to determine the prevalence of subclinical infection and the potential role of asymptomatic carriers in viral transmission.

1 January 2024 in Pesquisa Veterinária Brasileira
Verified
Journal Article
Open access
PDF file
VBVanessa C.T. Barraza
Vanessa C.T. Barraza
PBPedro Henrique S. Buttelli
Pedro Henrique S. Buttelli
IVIndianara de Vargas
Indianara de Vargas
MGMariana A. Goldani
Mariana A. Goldani
AMAlice M. de Medeiros
Alice M. de Medeiros
GKGlaucia D. Kommers
Glaucia D. Kommers
Lymph node status is considered an important clinical prognostic factor in canine mammary carcinomas and women’s breast neoplasms. However, occult isolated tumor cells (ITCs) can be missed during hematoxylin and eosin (HE) analyses. Immunohistochemistry (IHC) for cytokeratin can be used to detect carcinomatous occult ITCs in mammary drainage lymph nodes. However, brown pigments, such as hemosiderin and ceroid in lymph nodes, may hinder the search for occult metastases by IHC utilizing DAB (3,3′-diaminobenzidine) as the chromogen. The aim of this study was to identify ITCs in canine lymph nodes of cases in which it was not detectable by routine HE evaluation through IHC for cytokeratin (AE1/AE3) combined with histochemistry techniques, such as Perls’ Prussian blue and periodic acid-Schiff (PAS), to improve the detection of occult metastases when hemosiderin and ceroid were present in these lymph nodes. For this, 25 tubulopapillary mammary carcinomas with their respective submitted 29 regional lymph nodes, previously given as free of tumor cells by HE analyses, were selected. Mammary tumors were graduated, and vascular invasion was investigated in these tumors. The submitted lymph nodes were reevaluated in HE, looking for occult metastases. IHC for cytokeratin (AE1/AE3) was used to detect occult metastases in mammary lymph nodes. Subsequently, a combined technique of IHC with Perl’s Prussian blue (for hemosiderin) or PAS (for ceroid) was performed to optimize the detection of ITCs by IHC, distinguishing them from pigments. Occult metastases were classified by their microanatomical location in subcapsular, cortical and medullary. Hemosiderin and ceroid were searched in lymph nodes and quantified as low, moderate, or high. The amount of pigments with a percentage of ITCs was also compared. Isolated tumor cells were found in 24.1% (7/29) of mammary lymph nodes. These ITCs were located mainly in subcapsular sinuses (4/7; 57.1%), followed by cortical (2/7; 28.5%) and medullary sinuses (1/7; 14.3%). There were concomitant lymph nodes with ITCs in 33.4% (2/6) of cases with vascular invasion. Hemosiderin and ceroid were present in about 90% of the 29 lymph nodes analyzed. In 42.8% (3/7) of lymph nodes with ITCs, hemosiderin and/or ceroid were in the same location as ITCs. It was found that lymph nodes in which ITCs were detected also present high amounts of hemosiderin (3/7; 42.9%) and low amounts of ceroid (5/7; 71.4%). In this study, IHC for cytokeratin (AE1/AE3) was an efficient method to detect occult tumor cells. IHC combined with Perls’ Prussian blue or with PAS proved to be a helpful way to investigate the presence of occult metastases in the lymph nodes of mammary canine tumors. It allowed distinguishing hemosiderin and ceroid, respectively, from ITCs in the same slide of IHC (immunostained by DAB), favoring a more accurate analysis by pathologists, which can be useful for the oncological staging of these patients.